CODA Biotherapeutics
CODA Biotherapeutics, Inc. is a biopharmaceutical company that develops an innovative gene therapy platform for treating neurological disorders and diseases.
4
Funding Rounds
$62.7m
Money raised
Overview
CODA Biotherapeutics, Inc. is a biopharmaceutical company that develops an innovative gene therapy platform for treating neurological disorders and diseases.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company CODA Biotherapeutics has raised a total of $28m in funding over 4 rounds.
Key Insights:
- CODA Biotherapeutics , December 2021: $28m
- Coda Biotherapeutics Inc funding round, September 2018: $19m
- CODA Biotherapeutics Grant (money), November 2020: $670k
- CODA Biotherapeutics Series A round, November 2019: $15m
CODA Biotherapeutics , December 2021
$28m
Coda Biotherapeutics Inc funding round, September 2018
$19m
CODA Biotherapeutics Grant (money), November 2020
$670k
CODA Biotherapeutics Series A round, November 2019
$15m
Industries
CODA Biotherapeutics is active in the following industries: